Dr. Manal M Elmusa is a Bridgeview, Illinois based female chiropractor who is specialized as General Chiropractor. Active license number of Dr. Manal M Elmusa as General Chiropractor is 038012089 in Illinois. Dr. Manal M Elmusa is qualified as a Doctor of Chiropractic (D.C.), licensed by the State and who practices chiropractic medicine -that discipline within the healing arts which deals with the nervous system and its relationship to the spinal column and its interrelationship with other body systems.
Complete Profile:
Dr. Manal M Elmusa speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Chiropractor
Credentials:
D.C.
Gender:
Female
Practice Address:
7271 W 87th St, Bridgeview, Illinois, 60455-1821
Phone:
708-233-1100
Fax:
708-233-1102
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1467700526
NPI Enumeration Date:
21 Aug, 2012
NPI Last Update On:
03 Apr, 2013
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Manal M Elmusa are as mentioned below.
License Number
Specialization
State
Status
038012089
Chiropractor
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
7271 W 87th St, Bridgeview, Illinois
Zip:
60455-1821
Phone Number:
708-233-1100
Fax Number:
708-233-1102
Patients can reach Dr. Manal M Elmusa at 7271 W 87th St, Bridgeview, Illinois or can call to book an appointment on 708-233-1100. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.